CN102784240B - 一种治疗冠心病心绞痛藏药的制备方法 - Google Patents
一种治疗冠心病心绞痛藏药的制备方法 Download PDFInfo
- Publication number
- CN102784240B CN102784240B CN201210328717.XA CN201210328717A CN102784240B CN 102784240 B CN102784240 B CN 102784240B CN 201210328717 A CN201210328717 A CN 201210328717A CN 102784240 B CN102784240 B CN 102784240B
- Authority
- CN
- China
- Prior art keywords
- tibetan medicine
- preparation
- active component
- fructus
- angina pectoris
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 53
- 206010002383 Angina Pectoris Diseases 0.000 title claims abstract description 44
- 208000029078 coronary artery disease Diseases 0.000 title abstract description 9
- 238000000034 method Methods 0.000 title abstract description 4
- 210000000582 semen Anatomy 0.000 claims abstract description 16
- 239000002671 adjuvant Substances 0.000 claims abstract description 7
- 239000002552 dosage form Substances 0.000 claims abstract description 5
- 238000011282 treatment Methods 0.000 claims description 36
- 238000002360 preparation method Methods 0.000 claims description 20
- 239000009609 fructus phyllanthi Substances 0.000 claims description 15
- 240000004460 Tanacetum coccineum Species 0.000 claims description 14
- ROVGZAWFACYCSP-MQBLHHJJSA-N [2-methyl-4-oxo-3-[(2z)-penta-2,4-dienyl]cyclopent-2-en-1-yl] (1r,3r)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OC1C(C)=C(C\C=C/C=C)C(=O)C1 ROVGZAWFACYCSP-MQBLHHJJSA-N 0.000 claims description 14
- 229940015367 pyrethrum Drugs 0.000 claims description 14
- 229940079593 drug Drugs 0.000 claims description 12
- 239000000843 powder Substances 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 9
- 239000008187 granular material Substances 0.000 claims description 7
- 239000002775 capsule Substances 0.000 claims description 6
- 239000006187 pill Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 238000001556 precipitation Methods 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 2
- 239000000469 ethanolic extract Substances 0.000 claims description 2
- 238000007560 sedimentation technique Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 27
- 210000004369 blood Anatomy 0.000 abstract description 16
- 239000008280 blood Substances 0.000 abstract description 15
- 230000001737 promoting effect Effects 0.000 abstract description 8
- 208000002193 Pain Diseases 0.000 abstract description 6
- 230000017531 blood circulation Effects 0.000 abstract description 6
- 230000036407 pain Effects 0.000 abstract description 6
- 241001139841 Chrysanthemum tatsienense Species 0.000 abstract description 2
- 244000119298 Emblica officinalis Species 0.000 abstract description 2
- 235000015489 Emblica officinalis Nutrition 0.000 abstract description 2
- 240000000513 Santalum album Species 0.000 abstract description 2
- 235000008632 Santalum album Nutrition 0.000 abstract description 2
- 208000019622 heart disease Diseases 0.000 abstract description 2
- 235000018912 Chrysanthemum tatsienense Nutrition 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 201000010099 disease Diseases 0.000 description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 7
- 239000008103 glucose Substances 0.000 description 7
- 108010088842 Fibrinolysin Proteins 0.000 description 6
- 229940012957 plasmin Drugs 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 210000004556 brain Anatomy 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 206010003119 arrhythmia Diseases 0.000 description 4
- 230000006793 arrhythmia Effects 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 238000012856 packing Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- COXVTLYNGOIATD-HVMBLDELSA-N CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O Chemical compound CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O COXVTLYNGOIATD-HVMBLDELSA-N 0.000 description 3
- 229920000742 Cotton Polymers 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 208000019790 abdominal distention Diseases 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 230000002490 cerebral effect Effects 0.000 description 3
- 229960003699 evans blue Drugs 0.000 description 3
- 208000028867 ischemia Diseases 0.000 description 3
- 230000000302 ischemic effect Effects 0.000 description 3
- 230000003533 narcotic effect Effects 0.000 description 3
- 230000000284 resting effect Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 210000000115 thoracic cavity Anatomy 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 201000006474 Brain Ischemia Diseases 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010008120 Cerebral ischaemia Diseases 0.000 description 2
- 239000003390 Chinese drug Substances 0.000 description 2
- 241000871537 Choerospondias axillaris Species 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 206010018473 Glycosuria Diseases 0.000 description 2
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 2
- 235000014116 Spondias axillaris Nutrition 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000002785 anti-thrombosis Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000002146 bilateral effect Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 206010008118 cerebral infarction Diseases 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 201000005577 familial hyperlipidemia Diseases 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 229960003711 glyceryl trinitrate Drugs 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 238000000703 high-speed centrifugation Methods 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 210000004731 jugular vein Anatomy 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 208000031225 myocardial ischemia Diseases 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000001732 thrombotic effect Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 241000208223 Anacardiaceae Species 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 241001533085 Aquilaria sinensis Species 0.000 description 1
- 206010003175 Arterial spasm Diseases 0.000 description 1
- 206010003178 Arterial thrombosis Diseases 0.000 description 1
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 208000006770 Ascorbic Acid Deficiency Diseases 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000131317 Capitulum Species 0.000 description 1
- 208000020446 Cardiac disease Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 102000004420 Creatine Kinase Human genes 0.000 description 1
- 108010042126 Creatine kinase Proteins 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 241000221017 Euphorbiaceae Species 0.000 description 1
- 239000001828 Gelatine Substances 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 244000270834 Myristica fragrans Species 0.000 description 1
- 235000009421 Myristica fragrans Nutrition 0.000 description 1
- 241001081833 Myristicaceae Species 0.000 description 1
- 239000000006 Nitroglycerin Substances 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 241001529246 Platymiscium Species 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 241000221035 Santalaceae Species 0.000 description 1
- 241001534930 Thymelaeaceae Species 0.000 description 1
- 206010047623 Vitamin C deficiency Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000002876 beta blocker Substances 0.000 description 1
- 229940097320 beta blocking agent Drugs 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000001715 carotid artery Anatomy 0.000 description 1
- 210000001168 carotid artery common Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 238000011443 conventional therapy Methods 0.000 description 1
- 208000026758 coronary atherosclerosis Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000001361 intraarterial administration Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- -1 polyethylene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 208000010540 rapid respiration Diseases 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 208000010233 scurvy Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210328717.XA CN102784240B (zh) | 2012-09-07 | 2012-09-07 | 一种治疗冠心病心绞痛藏药的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210328717.XA CN102784240B (zh) | 2012-09-07 | 2012-09-07 | 一种治疗冠心病心绞痛藏药的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102784240A CN102784240A (zh) | 2012-11-21 |
CN102784240B true CN102784240B (zh) | 2014-01-08 |
Family
ID=47149959
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210328717.XA Active CN102784240B (zh) | 2012-09-07 | 2012-09-07 | 一种治疗冠心病心绞痛藏药的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102784240B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103385921A (zh) * | 2013-08-07 | 2013-11-13 | 王智森 | 一种治疗冠心病的药物组合物,制剂及其制备方法 |
-
2012
- 2012-09-07 CN CN201210328717.XA patent/CN102784240B/zh active Active
Non-Patent Citations (2)
Title |
---|
卡先加.藏药治疗风湿性心脏病50例.《中国民族医药杂志》.2005,(第04期),27. |
藏药治疗风湿性心脏病50例;卡先加;《中国民族医药杂志》;20050730(第04期);27 * |
Also Published As
Publication number | Publication date |
---|---|
CN102784240A (zh) | 2012-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104758353B (zh) | 一种治疗心血管疾病的药物组合物及其制备方法和用途 | |
CN102784240B (zh) | 一种治疗冠心病心绞痛藏药的制备方法 | |
CN101337017A (zh) | 一种治疗冠心病的药物 | |
CN102793801B (zh) | 一种治疗冠心病心绞痛的藏药 | |
CN103341069B (zh) | 一种治疗冠心病心绞痛的藏药及其制备方法 | |
CN107875365A (zh) | 一种治疗慢性肺源性心脏病的中药组合物及其制备方法 | |
CN107596244A (zh) | 一种治疗心脏病的中药及其制备方法 | |
CN104606511B (zh) | 一种预防微创治疗腰椎间盘突出症术后反跳现象的中药 | |
CN102698185B (zh) | 一种治疗高血脂症的藏药及其制备方法 | |
CN101632783B (zh) | 一种中药组合物在制备治疗肺原性心脏病药物中的应用 | |
CN102961604B (zh) | 一种治疗病毒性心肌炎的中药制剂 | |
CN104906399A (zh) | 一种治疗心脏病的中药丸剂及其制备方法 | |
CN110237211A (zh) | 一种治疗心脑血管的中药制剂及其制备方法 | |
CN104689241A (zh) | 一种治疗气滞血瘀型冠心病的药物及其制备方法 | |
CN109395045A (zh) | 一种治疗2型糖尿病湿热中阻证的清热化湿调糖丸及其制备方法 | |
CN104208369A (zh) | 治疗痛风的五藤逍遥丸 | |
CN104383422A (zh) | 一种用于治疗慢性胃病的中成药及其制备方法 | |
CN104257803A (zh) | 一种治疗打呼的药物组合物及其制备方法和用途 | |
CN108837010A (zh) | 一种治疗老年便秘的中药配方及其制备方法 | |
CN102861241B (zh) | 一种治疗急性心肌梗塞的中药补气化瘀汤 | |
CN103961603B (zh) | 一种降血脂通脉的中药制剂 | |
CN107837363A (zh) | 一种治疗慢性心率失常的中药组合物及其制备方法 | |
CN107875252A (zh) | 一种治疗慢性心衰的中药组合物、及其制备方法和用途 | |
CN106728828A (zh) | 一种治疗冠心病的中药制剂及其制备工艺 | |
CN105125886A (zh) | 一种用于预防和治疗糖尿病及其并发症的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Method for preparing traditional Tibetan medicine for treating coronary disease and stenocardia Effective date of registration: 20161213 Granted publication date: 20140108 Pledgee: JPMorgan Chase Bank Limited Pledgor: Jiumei Pengcuo Registration number: 2016630000007 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PM01 | Change of the registration of the contract for pledge of patent right | ||
PM01 | Change of the registration of the contract for pledge of patent right |
Change date: 20180620 Registration number: 2016630000007 Pledgee after: Datong silver rich village bank limited liability company Pledgee before: JPMorgan Chase Bank Limited |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20180625 Granted publication date: 20140108 Pledgee: Datong silver rich village bank limited liability company Pledgor: Jiumei Pengcuo Registration number: 2016630000007 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Method for preparing traditional Tibetan medicine for treating coronary disease and stenocardia Effective date of registration: 20180704 Granted publication date: 20140108 Pledgee: Datong silver rich village bank limited liability company Pledgor: Qinghai Jiumei Zang Drug Drug Co.Ltd.|Qinghai Tibetan Hospital Co., Ltd.|Jiumei Pengcuo Registration number: 2018630000005 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20210108 Granted publication date: 20140108 Pledgee: Datong silver rich village bank LLC Pledgor: Jiumei Pengcuo Registration number: 2018630000005 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A preparation method of Tibetan medicine for angina pectoris of coronary heart disease Effective date of registration: 20210125 Granted publication date: 20140108 Pledgee: Datong silver rich village bank LLC Pledgor: Jiumei Pengcuo Registration number: Y2021630000001 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |